RERG and breast fibrocystic disease: In addition, the distribution of either miR-382-5p or RERG was significantly different between benign breast disease controls and breast cancer cases (Figure 1I, p < 0.001 for miR-382-5p, and p = 0.009 for RERG, chi-square test).